Accellacare of Cary

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Psoriasis2 trials
• Chronic kidney disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Takeda2 trials
• Boehringer Ingelheim1 trial
• Carmot Therapeutics, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

  NCT06550076· Phase 3· Takeda· Source

Closed trials

• Completed

  A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

  NCT06628362· Phase 2· Carmot Therapeutics, Inc.· Source

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· Phase 3· Takeda· Source